{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:23:52Z","timestamp":1793931832884,"version":"4.8.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000185","name":"United States Department of Defense | Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["HR0011-18-2-0001"],"award-info":[{"award-number":["HR0011-18-2-0001"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI157155"],"award-info":[{"award-number":["AI157155"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["S10 OD030292"],"award-info":[{"award-number":["S10 OD030292"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI157155"],"award-info":[{"award-number":["AI157155"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI157155"],"award-info":[{"award-number":["AI157155"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The emergence of SARS-CoV-2 Omicron variants has led to viral escape from many clinically approved monoclonal antibodies (mAbs) due to rapid evolution of the receptor-binding domain (RBD). Co-circulation of SARS-CoV-2 variants with unique sets of antigenic substitutions has further complicated therapeutic mAb discovery. New approaches are needed to rapidly discover and characterize mAbs with preferred specificity and functional characteristics. Here we describe and perform epitope-focused mAb discovery using glycan-masked antigens. We isolated and expressed a panel of 303 mAbs, some of which potently neutralize divergent Omicron subvariants by targeting the class 3 antigenic site on SARS-CoV-2 RBD. Epitope mapping of these antibodies revealed a spectrum of cross-reactivity and differential recognition of the class 3 site, validating the utility of this enrichment approach for targeted mAb discovery. Together, this work rationally designs glycan-masked engineered RBDs and uses them to isolate mAbs that potently neutralize antigenically divergent SARS-CoV-2 variants.<\/jats:p>","DOI":"10.1038\/s41564-026-02282-x","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:02:09Z","timestamp":1773309729000},"page":"1113-1132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6712-5076","authenticated-orcid":false,"given":"Seth J.","family":"Zost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2571-1290","authenticated-orcid":false,"given":"Naveenchandra","family":"Suryadevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2725-5826","authenticated-orcid":false,"given":"Lauren E.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Scheaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Binshtein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2550-649X","authenticated-orcid":false,"given":"Cameron D.","family":"Buchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole V.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0210-8440","authenticated-orcid":false,"given":"Nicholas J.","family":"Catanzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ravera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel S.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1132-2550","authenticated-orcid":false,"given":"Luke","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit R.","family":"Ramamohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8658-4411","authenticated-orcid":false,"given":"Laura S.","family":"Handal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-6731","authenticated-orcid":false,"given":"Doan C.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Trivette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8260-6916","authenticated-orcid":false,"given":"James R.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5197-6367","authenticated-orcid":false,"given":"Eduardo","family":"Villalobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey A.","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6133-5942","authenticated-orcid":false,"given":"F.","family":"Eun-Hyung Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4760-4923","authenticated-orcid":false,"given":"Alexandra","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6827-8701","authenticated-orcid":false,"given":"Ralph S.","family":"Baric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-542X","authenticated-orcid":false,"given":"Jason S.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8791-3165","authenticated-orcid":false,"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5230-1532","authenticated-orcid":false,"given":"Robert H.","family":"Carnahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0049-1079","authenticated-orcid":false,"suffix":"Jr","given":"James E.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"2282_CR1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","volume":"588","author":"CO Barnes","year":"2020","unstructured":"Barnes, C. O. et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 588, 682\u2013687 (2020).","journal-title":"Nature"},{"key":"2282_CR2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24435-8","volume":"12","author":"AJ Greaney","year":"2021","unstructured":"Greaney, A. J. et al. Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies. Nat. Commun. 12, 4196 (2021).","journal-title":"Nat. Commun."},{"key":"2282_CR3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","volume":"602","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature 602, 657\u2013663 (2022).","journal-title":"Nature"},{"key":"2282_CR4","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.cell.2021.02.032","volume":"184","author":"W Dejnirattisai","year":"2021","unstructured":"Dejnirattisai, W. et al. The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell 184, 2183\u20132200.e22 (2021).","journal-title":"Cell"},{"key":"2282_CR5","doi-asserted-by":"crossref","unstructured":"Pinto, D. et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 583, 290\u2013295 (2020).","DOI":"10.1038\/s41586-020-2349-y"},{"key":"2282_CR6","unstructured":"Jones, B. E. et al. The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates. Sci. Transl. Med. 13, eabf1906 (2021)."},{"key":"2282_CR7","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110812","volume":"39","author":"K Westendorf","year":"2022","unstructured":"Westendorf, K. et al. LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants. Cell Rep. 39, 110812 (2022).","journal-title":"Cell Rep."},{"key":"2282_CR8","doi-asserted-by":"crossref","unstructured":"Hansen, J. et al. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science 369, 1010\u20131014 (2020).","DOI":"10.1126\/science.abd0827"},{"key":"2282_CR9","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/s41564-021-00972-2","volume":"6","author":"J Dong","year":"2021","unstructured":"Dong, J. et al. Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail. Nat. Microbiol. 6, 1233\u20131244 (2021).","journal-title":"Nat. Microbiol."},{"key":"2282_CR10","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa2116620","volume":"386","author":"MJ Levin","year":"2022","unstructured":"Levin, M. J. et al. Intramuscular AZD7442 (tixagevimab-cilgavimab) for prevention of Covid-19. N. Engl. J. Med. 386, 2188\u20132200 (2022).","journal-title":"N. Engl. J. Med."},{"key":"2282_CR11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41591-021-01678-y","volume":"28","author":"LA VanBlargan","year":"2022","unstructured":"VanBlargan, L. A. et al. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies. Nat. Med. 28, 490\u2013495 (2022).","journal-title":"Nat. Med."},{"key":"2282_CR12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","volume":"602","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature 602, 676\u2013681 (2022).","journal-title":"Nature"},{"key":"2282_CR13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41586-021-04386-2","volume":"602","author":"E Cameroni","year":"2022","unstructured":"Cameroni, E. et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature 602, 664\u2013670 (2022).","journal-title":"Nature"},{"key":"2282_CR14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cell.2021.12.046","volume":"185","author":"W Dejnirattisai","year":"2022","unstructured":"Dejnirattisai, W. et al. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell 185, 467\u2013484.e15 (2022).","journal-title":"Cell"},{"key":"2282_CR15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-022-04594-4","volume":"604","author":"S Iketani","year":"2022","unstructured":"Iketani, S. et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature 604, 553\u2013556 (2022).","journal-title":"Nature"},{"key":"2282_CR16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-022-05644-7","volume":"614","author":"Y Cao","year":"2023","unstructured":"Cao, Y. et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature 614, 521\u2013529 (2023).","journal-title":"Nature"},{"key":"2282_CR17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.chom.2020.11.007","volume":"29","author":"AJ Greaney","year":"2021","unstructured":"Greaney, A. J. et al. Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe 29, 44\u201357.e9 (2021).","journal-title":"Cell Host Microbe"},{"key":"2282_CR18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","volume":"584","author":"SJ Zost","year":"2020","unstructured":"Zost, S. J. et al. Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature 584, 443\u2013449 (2020).","journal-title":"Nature"},{"key":"2282_CR19","doi-asserted-by":"crossref","DOI":"10.1126\/science.abn7747","volume":"376","author":"T Zhou","year":"2022","unstructured":"Zhou, T. et al. Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529. Science 376, eabn8897 (2022).","journal-title":"Science"},{"key":"2282_CR20","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.chom.2021.04.005","volume":"29","author":"H Liu","year":"2021","unstructured":"Liu, H. et al. A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection. Cell Host Microbe 29, 806\u2013818.e6 (2021).","journal-title":"Cell Host Microbe"},{"key":"2282_CR21","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110561","volume":"38","author":"BM Hauser","year":"2022","unstructured":"Hauser, B. M. et al. Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting. Cell Rep. 38, 110561 (2022).","journal-title":"Cell Rep."},{"key":"2282_CR22","doi-asserted-by":"crossref","unstructured":"Duan, H. et al. Glycan masking focuses immune responses to the HIV-1 CD4-binding site and enhances elicitation of VRC01-class precursor antibodies. Immunity 49, 301\u2013311.e5 (2018).","DOI":"10.1016\/j.immuni.2018.07.005"},{"key":"2282_CR23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.chom.2019.04.003","volume":"25","author":"G Bajic","year":"2019","unstructured":"Bajic, G. et al. Influenza antigen engineering focuses immune responses to a subdominant but broadly protective viral epitope. Cell Host Microbe 25, 827\u2013835.e6 (2019).","journal-title":"Cell Host Microbe"},{"key":"2282_CR24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.immuni.2020.01.001","volume":"52","author":"P Gilchuk","year":"2020","unstructured":"Gilchuk, P. et al. Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization. Immunity 52, 388\u2013403.e12 (2020).","journal-title":"Immunity"},{"key":"2282_CR25","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41591-020-0998-x","volume":"26","author":"SJ Zost","year":"2020","unstructured":"Zost, S. J. et al. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein. Nat. Med. 26, 1422\u20131427 (2020).","journal-title":"Nat. Med."},{"key":"2282_CR26","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/s41551-020-0594-x","volume":"4","author":"P Gilchuk","year":"2020","unstructured":"Gilchuk, P. et al. Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics. Nat. Biomed. Eng. 4, 1030\u20131043 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"2282_CR27","volume":"26","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2. iScience 26, 108254 (2023).","journal-title":"iScience"},{"key":"2282_CR28","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1371\/journal.pmed.0030237","volume":"3","author":"J ter Meulen","year":"2006","unstructured":"ter Meulen, J. et al. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med. 3, e237 (2006).","journal-title":"PLoS Med."},{"key":"2282_CR29","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","volume":"368","author":"M Yuan","year":"2020","unstructured":"Yuan, M. et al. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science 368, 630\u2013633 (2020).","journal-title":"Science"},{"key":"2282_CR30","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JVI.02012-06","volume":"81","author":"PB McCray Jr.","year":"2007","unstructured":"McCray, P. B. Jr. et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 81, 813\u2013821 (2007).","journal-title":"J. Virol."},{"key":"2282_CR31","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","volume":"21","author":"ES Winkler","year":"2020","unstructured":"Winkler, E. S. et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat. Immunol. 21, 1327\u20131335 (2020).","journal-title":"Nat. Immunol."},{"key":"2282_CR32","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1073\/pnas.1712377114","volume":"114","author":"SJ Zost","year":"2017","unstructured":"Zost, S. J. et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc. Natl Acad. Sci. USA 114, 12578\u201312583 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2282_CR33","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl5842","volume":"6","author":"J Feldman","year":"2021","unstructured":"Feldman, J. et al. Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses. Sci. Immunol. 6, eabl5842 (2021).","journal-title":"Sci. Immunol."},{"key":"2282_CR34","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.cell.2019.11.003","volume":"179","author":"I Setliff","year":"2019","unstructured":"Setliff, I. et al. High-throughput mapping of B cell receptor sequences to antigen specificity. Cell 179, 1636\u20131646.e15 (2019).","journal-title":"Cell"},{"key":"2282_CR35","volume":"13","author":"LM Walker","year":"2022","unstructured":"Walker, L. M. et al. High-throughput B cell epitope determination by next-generation sequencing. Front. Immunol. 13, 855772 (2022).","journal-title":"Front. Immunol."},{"key":"2282_CR36","doi-asserted-by":"crossref","unstructured":"Zang, R. et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci. Immunol. 5, eabc3582 (2020).","DOI":"10.1126\/sciimmunol.abc3582"},{"key":"2282_CR37","doi-asserted-by":"crossref","unstructured":"Plante, J. A. et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature 592, 116\u2013121 (2021).","DOI":"10.1038\/s41586-020-2895-3"},{"key":"2282_CR38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm3302","volume":"14","author":"B Ying","year":"2022","unstructured":"Ying, B. et al. Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains. Sci. Transl. Med. 14, eabm3302 (2022).","journal-title":"Sci. Transl. Med."},{"key":"2282_CR39","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41591-021-01294-w","volume":"27","author":"RE Chen","year":"2021","unstructured":"Chen, R. E. et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat. Med. 27, 717\u2013726 (2021).","journal-title":"Nat. Med."},{"key":"2282_CR40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.710263","volume":"12","author":"D Ellis","year":"2021","unstructured":"Ellis, D. et al. Stabilization of the SARS-CoV-2 spike receptor-binding domain using deep mutational scanning and structure-based design. Front. Immunol. 12, 710263 (2021).","journal-title":"Front. Immunol."},{"key":"2282_CR41","doi-asserted-by":"crossref","first-page":"14756","DOI":"10.1074\/jbc.270.24.14756","volume":"270","author":"L Kasturi","year":"1995","unstructured":"Kasturi, L., Eshleman, J. R., Wunner, W. H. & Shakin-Eshleman, S. H. The hydroxy amino acid in an Asn-X-Ser\/Thr sequon can influence N-linked core glycosylation efficiency and the level of expression of a cell surface glycoprotein. J. Biol. Chem. 270, 14756\u201314761 (1995).","journal-title":"J. Biol. Chem."},{"key":"2282_CR42","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116052","volume":"44","author":"E Olmedillas","year":"2025","unstructured":"Olmedillas, E. et al. Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformation. Cell Rep. 44, 116052 (2025).","journal-title":"Cell Rep."},{"key":"2282_CR43","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","volume":"114","author":"J Pallesen","year":"2017","unstructured":"Pallesen, J. et al. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc. Natl Acad. Sci. USA 114, E7348\u2013E7357 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2282_CR44","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","volume":"369","author":"CL Hsieh","year":"2020","unstructured":"Hsieh, C. L. et al. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science 369, 1501\u20131505 (2020).","journal-title":"Science"},{"key":"2282_CR45","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cell.2024.01.034","volume":"187","author":"YX Tsai","year":"2024","unstructured":"Tsai, Y. X. et al. Rapid simulation of glycoprotein structures by grafting and steric exclusion of glycan conformer libraries. Cell 187, 1296\u20131311.e26 (2024).","journal-title":"Cell"},{"key":"2282_CR46","volume":"9","author":"DC Nguyen","year":"2018","unstructured":"Nguyen, D. C. et al. Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion. Nat. Commun. 9, 3698 (2018).","journal-title":"Nat. Commun."},{"key":"2282_CR47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12859-020-03649-5","volume":"21","author":"C Soto","year":"2020","unstructured":"Soto, C. et al. PyIR: a scalable wrapper for processing billions of immunoglobulin and T cell receptor sequences using IgBLAST. BMC Bioinformatics. 21, 314 (2020).","journal-title":"BMC Bioinformatics."},{"key":"2282_CR48","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.4049\/jimmunol.1601850","volume":"198","author":"NT Gupta","year":"2017","unstructured":"Gupta, N. T. et al. Hierarchical clustering can identify B cell clones with high confidence in Ig repertoire sequencing data. J. Immunol. 198, 2489\u20132499 (2017).","journal-title":"J. Immunol."},{"key":"2282_CR49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen, P. et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261\u2013272 (2020).","journal-title":"Nat. Methods"},{"key":"2282_CR50","doi-asserted-by":"crossref","unstructured":"Crawford, K. H. D. et al. Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays. Viruses 12, 513 (2020).","DOI":"10.3390\/v12050513"},{"key":"2282_CR51","volume":"3","author":"N Suryadevara","year":"2022","unstructured":"Suryadevara, N. et al. Real-time cell analysis: a high-throughput approach for testing SARS-CoV-2 antibody neutralization and escape. STAR Protoc. 3, 101387 (2022).","journal-title":"STAR Protoc."},{"key":"2282_CR52","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.immuni.2021.08.016","volume":"54","author":"LA VanBlargan","year":"2021","unstructured":"VanBlargan, L. A. et al. A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope. Immunity 54, 2399\u20132416.e6 (2021).","journal-title":"Immunity"},{"key":"2282_CR53","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1126\/science.abe8499","volume":"370","author":"YJ Hou","year":"2020","unstructured":"Hou, Y. J. et al. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo. Science 370, 1464\u20131468 (2020).","journal-title":"Science"},{"key":"2282_CR54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1251\/bpo70","volume":"6","author":"M Ohi","year":"2004","unstructured":"Ohi, M., Li, Y., Cheng, Y. & Walz, T. Negative staining and image classification \u2013 powerful tools in modern electron microscopy. Biol. Proced. Online 6, 23\u201334 (2004).","journal-title":"Biol. Proced. Online"},{"key":"2282_CR55","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"2282_CR56","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"2282_CR57","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"2282_CR58","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jsb.2015.08.007","volume":"192","author":"JL Rubinstein","year":"2015","unstructured":"Rubinstein, J. L. & Brubaker, M. A. Alignment of cryo-EM movies of individual particles by optimization of image translations. J. Struct. Biol. 192, 188\u2013195 (2015).","journal-title":"J. Struct. Biol."},{"key":"2282_CR59","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"2282_CR60","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s42003-021-02399-1","volume":"4","author":"R Sanchez-Garcia","year":"2021","unstructured":"Sanchez-Garcia, R. et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Commun. Biol. 4, 874 (2021).","journal-title":"Commun. Biol."},{"key":"2282_CR61","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.abn8652","volume":"375","author":"M McCallum","year":"2022","unstructured":"McCallum, M. et al. Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement. Science 375, 864\u2013868 (2022).","journal-title":"Science"},{"key":"2282_CR62","doi-asserted-by":"crossref","first-page":"W474","DOI":"10.1093\/nar\/gkw361","volume":"44","author":"J Dunbar","year":"2016","unstructured":"Dunbar, J. et al. SAbPred: a structure-based antibody prediction server. Nucleic Acids Res. 44, W474\u2013W478 (2016).","journal-title":"Nucleic Acids Res."},{"key":"2282_CR63","doi-asserted-by":"crossref","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213\u2013221 (2010).","DOI":"10.1107\/S0907444909052925"},{"key":"2282_CR64","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1107\/S0907444902016657","volume":"58","author":"PD Adams","year":"2002","unstructured":"Adams, P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D 58, 1948\u20131954 (2002).","journal-title":"Acta Crystallogr. D"},{"key":"2282_CR65","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D"},{"key":"2282_CR66","doi-asserted-by":"crossref","unstructured":"Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D 74, 519\u2013530 (2018).","DOI":"10.1107\/S2059798318002425"},{"key":"2282_CR67","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"2282_CR68","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"2282_CR69","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18952-1","volume":"11","author":"T Bepler","year":"2020","unstructured":"Bepler, T., Kelley, K., Noble, A. J. & Berger, B. Topaz-Denoise: general deep denoising models for cryoEM and cryoET. Nat. Commun. 11, 5208 (2020).","journal-title":"Nat. Commun."},{"key":"2282_CR70","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SH Scheres","year":"2012","unstructured":"Scheres, S. H. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519\u2013530 (2012).","journal-title":"J. Struct. Biol."},{"key":"2282_CR71","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1042\/BCJ20210708","volume":"478","author":"D Kimanius","year":"2021","unstructured":"Kimanius, D., Dong, L., Sharov, G., Nakane, T. & Scheres, S. H. W. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem. J. 478, 4169\u20134185 (2021).","journal-title":"Biochem. J."},{"key":"2282_CR72","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41586-023-06487-6","volume":"621","author":"A Addetia","year":"2023","unstructured":"Addetia, A. et al. Neutralization, effector function and immune imprinting of Omicron variants. Nature 621, 592\u2013601 (2023).","journal-title":"Nature"},{"key":"2282_CR73","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s42003-023-04927-7","volume":"6","author":"B Abanades","year":"2023","unstructured":"Abanades, B. et al. ImmuneBuilder: deep-learning models for predicting the structures of immune proteins. Commun. Biol. 6, 575 (2023).","journal-title":"Commun. Biol."},{"key":"2282_CR74","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"2282_CR75","unstructured":"The PyMOL Molecular Graphics System version 1.8 (Schrodinger, 2015)."},{"key":"2282_CR76","doi-asserted-by":"crossref","unstructured":"Kabsch, W. XDS. Acta Crystallogr. D 66, 125\u2013132 (2010).","DOI":"10.1107\/S0907444909047337"},{"key":"2282_CR77","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Crystallogr. D 69, 1204\u20131214 (2013).","journal-title":"Acta Crystallogr. D"},{"key":"2282_CR78","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"2282_CR79","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"2282_CR80","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","volume":"19","author":"M Mirdita","year":"2022","unstructured":"Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat. Methods 19, 679\u2013682 (2022).","journal-title":"Nat. Methods"},{"key":"2282_CR81","doi-asserted-by":"publisher","unstructured":"Evans, R. et al. Protein complex prediction with AlphaFold-Multimer. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.10.04.463034 (2022).","DOI":"10.1101\/2021.10.04.463034"},{"key":"2282_CR82","unstructured":"Soto, C. et al. PyIR. GitHub https:\/\/github.com\/crowelab\/PyIR (2021)."}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-026-02282-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-026-02282-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-026-02282-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:02:30Z","timestamp":1775574150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-026-02282-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":82,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["2282"],"URL":"https:\/\/doi.org\/10.1038\/s41564-026-02282-x","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"16 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.J.Z. has served as a consultant for RenBio, Inc. L.E.W. has served as a consultant for BigHat Biosciences. M.S.D. is a consultant or advisor for Inbios, Vir Biotechnology, IntegerBio, Akagera Medicines, Moderna, Merck, and GlaxoSmithKline. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Moderna, Vir Biotechnology, and Emergent BioSolutions. J.E.C. has served as a consultant for Luna Labs USA, Merck Sharp & Dohme Corporation, and Emergent Biosolutions; is a former member of the Scientific Advisory Boards of Meissa Vaccines, Gigagen (Grifols) and BTG International Inc; and is founder of IDBiologics. The laboratory of J.E.C. received unrelated sponsored research agreements from AstraZeneca, Takeda Vaccines, and IDBiologics during the conduct of the study. Vanderbilt University has applied for a patent concerning antibodies that are related to this work (US Provisional Patent Application No. 63\/513,255). D.C.N. and F.E.-H.L. are co-inventors of patents filed by Emory University pertaining to the plasma cell survival medium used in this paper (US11124766B2, US11125757B2, US12163965B2 and US12173315B2). R.S.B. is a member of advisory boards for VaxArt, Takeda and Invivyd, and has collaborative projects with Gilead, Johnson & Johnson, and Hillevax, focused on unrelated projects. R.S.B. is an inventor of methods and uses of mouse-adapted SARS-CoV-2 viruses (US patent US11225508B1). All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}